Director, medical affairs, switzerland

PpRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s RAQ pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC‑6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC‑9805), a RAS(ON) G12D‑selective inhibitor; and RMC‑5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. /p h3The Opportunity /h3 pReporting to the Country Manager Switzerland, the Medical Director, Switzerland is the medical leader responsible for defining and executing the local medical strategy RevMed portfolio and launches. This role serves as the medical voice within the Switzerland Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. /p pThis leader will ensure that Switzerland medical considerations are embedded in the regional medical strategy and plans and will partner with the Country Manager and cross‑functional teams, as well as the Sr Dir Medical Affairs Midsized Markets and VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Switzerland medical team and work closely with the Midsized Markets cross‑functional and cross‑country teams, Global and Regional Medical Affairs teams across Med Affairs functions. /p h3Required Experience /h3 ul liAct as the Medical Affairs lead for Switzerland, accountable for local medical strategy, execution, and impact across the oncology portfolio. /li liTranslate global medical and clinical strategies into locally relevant medical plans aligned with country regulations and clinical practice. /li liBuild and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies. /li liLead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level. /li liCollaborate effectively with Midsized Markets, Regional and Global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams. /li liDrive local medical strategy across pre‑launch, launch, and post‑launch phases. /li liProvide local medical expertise on evidence generation activities including local studies, real‑world evidence initiatives, and investigator‑initiated research (where permitted). /li liEnsure effective execution of publication plans and scientific communication activities. /li liLead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans. /li liPartner with Market Access and Commercial teams to support value communication and reimbursement‑related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings. /li liSupport lifecycle management activities including new indications, label updates, and competitive positioning. /li liWork closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans. /li liProvide medical review and approval of non‑promotional materials in accordance with local regulations and company policies. /li liBuild, lead, and develop the country Medical Affairs team when/if applicable, including Medical advisors and MSLs. /li liEstablish medical processes, governance, and ways of working as part of the country build‑out. /li liFoster a culture of scientific rigor, compliance, and collaboration. /li liEnsure all medical activities comply with local regulations, national and regional codes, and internal company policies. /li liRepresent Medical Affairs in country governance and risk management forums. /li /ul h3Required Skills, Experience and Education /h3 ul liAdvanced degree required (MD, PhD, or PharmD). /li liStrong background and experience in oncology required. /li li10+ years’ experience in Medical Affairs with a track record of country leadership. /li liProven value and benefit assessment experience, with deep understanding of Switzerland payer decision‑making. /li liStrong stakeholder management and ability to collaborate with internal and external partners. /li liProven experience supporting oncology product launches in Switzerland. /li liStrong understanding of the local healthcare system, clinical practice, and regulatory environment. /li liExperience in a biotech and/or in a build‑out. /li liExcellent communication skills, both in person and virtual. /li liProven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment. /li liScientific and solution‑orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment. /li liStrong understanding of local healthcare systems, customer dynamics, and reimbursement environments. /li liWillingness to travel nationally and internationally. /li /ul /p #J-18808-Ljbffr